Question 1

Has Lawrence Reccoppa received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $968,069 in general payments to Lawrence Reccoppa across 1,441 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Lawrence Reccoppa did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Lawrence Reccoppa come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	577	$385,813
Vanda Pharmaceuticals Inc.	320	$209,710
Alkermes, Inc.	174	$135,232
E.r. Squibb & Sons, L.L.C.	161	$122,746
Sunovion Pharmaceuticals Inc.	106	$68,676
Otsuka Pharmaceutical Development & Commercialization, Inc.	29	$25,637
AbbVie(2 entities)	21	$10,645
Supernus Pharmaceuticals, Inc.	18	$8,411
Teva Pharmaceuticals USA, Inc.	15	$538
Neurocrine Biosciences, Inc.	9	$359
Otsuka America Pharmaceutical, Inc.	4	$160
Johnson & Johnson	5	$97
Axsome Therapeutics, Inc.	2	$46

Lawrence Reccoppa

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Gainesville